Has Subhash Sheth received payments from drug or device companies?

Yes. Drug and device makers reported $1,424 in general payments to Subhash Sheth across 71 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Subhash Sheth did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Subhash Sheth come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Subhash Sheth

Medical Oncology · Louisville, KYNPI 1942201652

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for medical oncology clinicians in KY, where the typical reported total is $3,396.

$1,424in general payments, 2019–2025

Across 71 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$196
Novartis$168
Abiomed$146
Merck$133
Sirtex Medical Inc$128
AstraZeneca$111
plus $542 from 18 others

What the payments were for

Food & beverage$1,41299%
Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	5	$196
Novartis	11	$168
Abiomed	1	$146
Merck	8	$133
Sirtex Medical Inc	1	$128
AstraZeneca	8	$111
Amgen	5	$73
Beigene USA, Inc.	4	$57
Pfizer	4	$51
Gilead	3	$48
E.r. Squibb & Sons, L.L.C.	2	$38
Seagen Inc.	2	$36
Eisai Inc.	2	$31
Array Biopharma Inc	2	$28
Daiichi Sankyo Inc.	2	$28
Rigel Pharmaceuticals, Inc.	2	$27
Kyowa Kirin, Inc.	2	$25
Bristol Myers Squibb	1	$18
Ipsen Biopharmaceuticals, Inc	1	$18
Johnson & Johnson	1	$14
Teva Pharmaceuticals USA, Inc.	1	$14
Acceleron Pharma, Inc.	1	$13
GSK	1	$12
Lilly USA, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SIR-Spheres Microspheres$128
FABRAZYME$122

How this compares

$1,424 in reported general payments places this provider in the 40th percentile of 53 medical oncology providers in Kentucky.

See all medical oncology providers in Kentucky →

Other medical oncology in Louisville

Emmanuel NidhiryLouisville$34K
John HammLouisville$26K
Renato la RoccaLouisville$24K
Vijay RaghavanLouisville$17K
Don StevensLouisville$16K
Douglas NelsonLouisville$8K
Michael DriscollLouisville$2K
Thomas WoodcockLouisville$57
Janell SeegerLouisville$12
Joseph FlynnLouisville$0

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →